7
Nov
Manufacturing Changes and Generic Approval: What Triggers FDA Re-Evaluation
Medications

Manufacturing Changes and Generic Approval: What Triggers FDA Re-Evaluation

Understand what manufacturing changes trigger FDA re-evaluation for generic drugs, including PAS, CBE, and Annual Report submissions, review timelines, and how new programs are speeding up approvals for U.S.-made products.

William Blehm